The ONO/MEDX anti-PD-1[now BMY] when combined with ipilimumab[Yervoy] wiped out all signs of tumor preclinically in mice. Individually, the compounds were not THAT successful. I do not know whether quackinvestor's profile showing that graphical result is available anymore on former Y! or Investor Village boards.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.